EL7.AI
StocksMedium•20 August 2026•
1 min read

Vext Reports 22% Adjusted EBITDA Growth in Q2 2026 Amid Ohio Expansion

Key Facts

1Vext reported Q2 2026 revenue of $12.1 million, remaining level with the first quarter of 2026.
2Adjusted EBITDA grew by 22% from Q1 2026 to reach $3.4 million.
3Net loss narrowed by 79% year-over-year to $(0.3) million.

Amid shifting dynamics in the North American cannabis sector, Vext Science's Q2 2026 results highlighted a significant drive toward operational efficiency. According to reports, the company generated $12.1 million in revenue, holding steady compared to the first quarter of 2026. Notably, the firm succeeded in narrowing its net loss by 79% year-over-year to $0.3 million, demonstrating progress in its cost-management strategy.

Operationally, adjusted EBITDA grew by 22% to reach $3.4 million compared to Q1 2026. This growth was primarily supported by the company's expansion in the Ohio market, which helped offset the planned wind-down of cultivation and wholesale activities in Arizona. This strategic pivot reflects management's focus on higher-margin markets to bolster long-term financial stability.

Moving forward, market participants are watching the impact of the recently closed $17 million real estate financing and the opening of a sixth dispensary in Ohio as key catalysts for future revenue growth.